SCHEMBL8330846

SCHEMBL8330846

O=C(O)C(CCCC1CCCCC1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
METAP1 P53582 1/20 0.43
KDM5A P29375 3/20 0.42
PHF8 Q9UPP1 3/20 0.42
KDM2A Q9Y2K7 3/20 0.42
KDM4C Q9H3R0 2/20 0.42
KDM4A O75164 1/20 0.42
SIGMAR1 Q99720 3/20 0.42
MAPT P10636 1/20 0.41
EPHX1 P07099 1/20 0.41
HPGD P15428 1/20 0.40
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11223456 1.00 CYP1A2 (0.45) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL16732010 0.98 MAPT (0.42) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL23833698 0.92 SIGMAR1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL6192922 0.89 CYP1A2 (0.44) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28014935 0.87 METAP1 (0.50) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28875946 0.85 METAP1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28875904 0.85 METAP1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28315546 0.85 METAP1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28315755 0.85 METAP1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A
SCHEMBL28315748 0.85 METAP1 (0.48) CYP1A2METAP1KDM5APHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908863-A ANTIGROWTH AGENT FOR BONES DOMPE' S.P.A. (IT) 1999-06-01 US disclosed
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed